CoChat

Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function

Open access
Feng, Felix Y., de Bono, Johann S., Rubin, Mark A., Knudsen, Karen E. · 2015 · Molecular Cell
Cited by 132

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Poly(ADP-ribose) polymerase 1 (PARP1) inhibitors were recently shown to have clinical impact in a number of disease settings, particularly as related to cancer therapy, treatment for cardiovascular dysfunction, and suppression of inflammation. The molecular basis for PARP1 inhibitor function is complex, and appears to depend on the dual roles of PARP1 in DNA damage repair and transcriptional regulation. Here, the mechanisms by which PARP-1 inhibitors elicit clinical response are discussed, and strategies for translating the preclinical elucidation of PARP-1 function into advances in disease management are reviewed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2015.04.016

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 132

Metadata

Authors
Feng, F. Y., de Bono, J. S., Rubin, M. A., & Knudsen, K. E.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2015-06
Volume
58
Issue
6
Pages
925-934
ISSN
1097-2765 (ISSN-L)
OpenAlex
W1842469464
Cited by
132
References
11
FWCI
9.10
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function. https://app.cochat.ai/papers/10.1016/j.molcel.2015.04.016
The paper
Feng, F. Y., de Bono, J. S., Rubin, M. A., & Knudsen, K. E. (2015). Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function. Molecular Cell. https://doi.org/10.1016/j.molcel.2015.04.016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.